Estimated Control Closed Transaction verified Supplements

Atrium Innovations Inc. acquired by Permira Advisers Ltd.

Permira Advisers Ltd. acquired Atrium Innovations Inc., a Canadian vitamins & supplements brand, on Feb 13, 2014.

Transaction summary

Target
Atrium Innovations Inc.
Seller
-
Announced
2013-11-29
Completed
2014-02-13
Geography
Canada
Tags
Supplements
2 more tags
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-13
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 1.0B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

-

Period: LTM

Basis: Public source

EV / EBITDA

10.8x

EBITDA: normalised / adjusted

Basis: Public source

Basis

  • Atrium Innovations agreed on 29 November 2013 to be acquired by a company backed by the Permira funds for C$24.00 a share in cash, an enterprise value of about C$1.1bn including debt, and the deal completed on 13 February 2014. Afterwards the Permira funds held 75%, and Fonds de solidarité FTQ and CDPQ 12.5% each, before management equity. EV/EBITDA is the 10.8x LTM adjusted EBITDA multiple in Canaccord Genuity's precedent transactions table (Thorne HealthTech, 2023), which gives the value as US$1,036m.

Source summary

Atrium Innovations Inc. to be acquired by the Permira funds and a group of Québec investors

Confirmed

The transaction represents a total enterprise value of approximately $1.1 billion, including the assumption of existing indebtedness, for 100% of Atrium.

Open source

Atrium Innovations announces completion of acquisition by the Permira funds

Confirmed

announced today the successful completion of the previously announced plan of arrangement

Open source

Thorne HealthTech Schedule 14D-9/A

Estimated

Canaccord Genuity's selected precedent transactions (US$ in millions) list November 2013, Permira Advisers Ltd. and Atrium Innovations Inc.: implied TEV $1,036, TEV / LTM Adjusted EBITDA 10.8x.

Open source

Continue your research

Explore more comps →